IFG Advisory LLC boosted its holdings in Cigna Group (NYSE:CI – Free Report) by 14.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,807 shares of the health services provider’s stock after purchasing an additional 1,726 shares during the period. IFG Advisory LLC’s holdings in Cigna Group were worth $3,753,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Danske Bank A S lifted its position in Cigna Group by 3.1% during the 3rd quarter. Danske Bank A S now owns 140,194 shares of the health services provider’s stock worth $38,109,000 after buying an additional 4,215 shares in the last quarter. McKinney Capital Management LLC acquired a new position in shares of Cigna Group during the 3rd quarter worth about $1,373,000. Diversified Trust Co boosted its stake in shares of Cigna Group by 42.1% during the 3rd quarter. Diversified Trust Co now owns 4,429 shares of the health services provider’s stock worth $1,204,000 after buying an additional 1,313 shares during the last quarter. Vista Capital Partners Inc. bought a new position in shares of Cigna Group in the 3rd quarter valued at about $332,000. Finally, Aberdeen Group plc grew its holdings in shares of Cigna Group by 389.6% in the 3rd quarter. Aberdeen Group plc now owns 1,078,857 shares of the health services provider’s stock valued at $283,907,000 after acquiring an additional 858,488 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on CI. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Thursday, August 27th. Sanford C. Bernstein raised their price target on Cigna Group from $387.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday. Piper Sandler lowered their price target on Cigna Group from $370.00 to $360.00 and set an “overweight” rating on the stock in a research report on Thursday. Barclays upped their price objective on Cigna Group from $310.00 to $320.00 and gave the stock an “equal weight” rating in a research note on Monday, November 9th. Finally, Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their price objective for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $336.90.
View Our Latest Stock Analysis on Cigna Group
Top Cigna Group Stories
These are some of the CI stories that stood out recently:
- Positive Sentiment: Coverage points to a raised earnings outlook following a strong third quarter, which could improve expectations for future results. CIBC also included Cigna in a defensive stock-pick list. Cigna earnings outlook CIBC defensive stock-pick list
- Neutral Sentiment: Analyst sentiment remains moderately bullish overall, although coverage notes Cigna has lagged industry peers and the broader market. Analyst sentiment overview
- Negative Sentiment: Piper Sandler trimmed its target from $370 to $360, though it retained an overweight rating. Separately, CIBC cited the possibility of a tougher regulatory environment after the election as a risk for corporate America. Piper Sandler target revision CIBC election-related context
Cigna Group Trading Down 0.1%
Shares of CI stock opened at $296.79 on Monday. The firm has a 50 day moving average price of $287.53 and a two-hundred day moving average price of $282.70. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $78.20 billion, a PE ratio of 13.10, a price-to-earnings-growth ratio of 1.11 and a beta of 0.25. Cigna Group has a 12-month low of $257.85 and a 12-month high of $318.05.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The firm had revenue of $73.79 billion for the quarter, compared to analyst estimates of $72.64 billion. During the same period in the prior year, the firm posted $7.83 EPS. The company’s revenue for the quarter was up 5.6% on a year-over-year basis. As a group, analysts predict that Cigna Group will post 30.71 earnings per share for the current year.
Cigna Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be given a $1.56 dividend. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group’s payout ratio is presently 27.54%.
Insider Activity at Cigna Group
In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.
Cigna Group Company Profile
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
Featured Articles
- Five stocks we like better than Cigna Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
